FDA Inspection
Amnii-X LLCAmnii-X LLC – FDA Inspection, Feb 20, 2018
Record Details
This FDA Inspection record concerns Amnii-X LLC, with an inspection on February 20, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · b8fae46d-204e-4965-af8a-4c0ecbc8ac2a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1042385
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.260(d)Corrective actions
- 21 CFR 1271.260(a)Contamination, mix ups, improper release
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Amnii-X LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2025 | Not classified | Dallas District Office | |
| March 31, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Amnii-X LLC
- FDA Inspection 1262171 - 2025-02-18
- FDA Inspection 872278 - 2014-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.